Teva and Prestige Biopharma enter license agreement for Tuznue commercialization in Europe
Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients
Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients
Advancing clinical pharmacokinetic prediction beyond non-human primate models
New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA
Find out how Streck is adapting to evolving clinical lab needs by providing quality controls for automated molecular diagnostics
Find out why millions of cases of hepatitis B and C are going undiagnosed and how clinical labs could play an important role in getting more people tested and treated
Sensitive biophysical characterization techniques have revolutionized drug discovery. Label-free biophysical techniques like bio-layer interferometry (BLI), surface plasmon resonance (SPR) and grating coupled interferometry (GCI) are now key components in drug discovery platforms. In this eBook, we take an in-depth look at each of these biophysical methods and the platforms available.
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helping clinicians distinguish dengue from other acute fever-causing illnesses